slides · global inventory
Quote
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 18,554
Current window 15,421-15,450
Pages 619
Rows per page 30
Component
15,421-15,450 of 18,554
29
Uses patient testimonials as primary evidence to challenge the safety profile of the drug.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
30
The slide uses direct quotes from Facebook groups to undermine the product's safety/efficacy narrative.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
36
The slide uses a Q&A format to highlight potential corporate malfeasance regarding clinical trial safety reporting.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
37
The slide uses a 'villain' narrative by framing patient advocacy groups as manipulators of the regulatory process.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
40
The slide uses a combination of narrative summary and direct Q&A transcript excerpts to build a case of potential clinical trial misconduct.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
41
The slide uses a 'villain' framing to question the validity of Soleno Therapeutics' clinical trial results.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
42
The slide uses a Q&A format to highlight internal skepticism regarding clinical trial data.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
43
The slide uses a 'quote-highlight' structure to emphasize specific allegations of misconduct.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
44
The slide uses a Q&A format to present whistleblower testimony.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
45
The slide uses strong, accusatory language ('hoax', 'scientifically unfounded', 'misleading') to attack the target company's scientific rationale.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
47
The slide uses screenshots of social media posts as primary evidence to challenge the clinical narrative.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
51
The slide uses visual evidence to argue for data fabrication in a clinical trial report.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
55
The slide uses a 'villain_critique' approach by leveraging an expert's authority to discredit the company's product.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
56
The slide uses direct quotes from an expert to highlight risks of cardiac events, seizures, and trial design flaws.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
57
The slide uses direct quotes from an expert to undermine the viability of the company's drug formulation.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
60
The slide uses direct quotes from an expert to discredit a competitor's clinical trial results.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
61
This slide presents expert testimony/critique from a trial investigator, serving as a 'villain_critique' or 'expose_contradiction' style slide.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
62
The slide uses a 'nominee_bio' structure to present a 'villain_critique' or 'expose_contradiction' narrative.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
63
The slide uses direct quotes to expose potential data omissions and competitive disadvantage.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
64
The slide uses direct quotes from an expert to undermine the commercial viability and clinical efficacy of the drug.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
65
The slide uses direct quotes from a trial investigator to undermine the drug's efficacy and safety profile.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
66
This slide is part of a series of 'investigator' profiles used to build a case against a company's clinical trial results.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
67
The slide presents critical expert feedback on drug formulation and safety protocols.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
68
The slide uses a 'villain' or 'expert critic' framing to undermine the credibility of a clinical trial and its associated drug.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
69
The slide uses direct quotes from an expert to undermine the value proposition of the subject company's product.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
70
The slide uses a series of bullet points to contrast public posturing with private admissions.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
71
The slide uses specific quotes from an investigator to undermine the validity of clinical trial results and highlight potential adverse events.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
74
The slide uses direct quotes to undermine the credibility of the drug's approval and market demand.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
75
The slide uses direct quotes from an expert consultation to undermine the company's product launch and clinical efficacy claims.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
76
The slide uses a direct quote to highlight medical risks that could limit the drug's market potential.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit